BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Monday, January 26, 2026
Home » Authors » Kim Coghill

Articles by Kim Coghill

Synthetic Blood Gains Access To $20M Equity Credit Line

June 4, 2002
By Kim Coghill

FDA Says Animal Studies Enough For Drugs To Counter Bioterrorism

June 3, 2002
By Kim Coghill
WASHINGTON - A new FDA regulation allows drugs developed as antidotes to biological and chemical warfare to gain regulatory approval based on animal studies when human efficacy trials are not ethical. (BioWorld Today)
Read More

FDA Says Animal Studies Enough For Drugs To Counter Bioterrorism

June 3, 2002
By Kim Coghill
WASHINGTON - A new FDA regulation allows drugs developed as antidotes to biological and chemical warfare to gain regulatory approval based on animal studies when human efficacy trials are not ethical. (BioWorld Today)
Read More

Biotech Officials Push Harder To Get FDA Leader Appointed

May 31, 2002
By Kim Coghill
WASHINGTON - Every now and then when a drug doesn't win FDA approval, someone in the background can be heard blaming the failure on a lack of leadership at the government agency. (BioWorld Today)
Read More

Biotech Officials Push Harder To Get FDA Leader Appointed

May 31, 2002
By Kim Coghill
WASHINGTON - Every now and then when a drug doesn't win FDA approval, someone in the background can be heard blaming the failure on a lack of leadership at the government agency. (BioWorld Today)
Read More

Study Reports Most New Drug Approvals Based On Old Science

May 30, 2002
By Kim Coghill

Study Reports Most New Drug Approvals Based On Old Science

May 30, 2002
By Kim Coghill

Lilly ICOS's Cialis Demonstrates Efficacy In ED At 24, 36 Hours

May 29, 2002
By Kim Coghill
Lilly ICOS LLC's proposed drug for erectile dysfunction apparently gives men the ability to achieve an erection some 24 to 36 hours after taking it. Comparatively, Pfizer Inc.'s blockbuster drug Viagra offers only an eight-hour window. (BioWorld Today)
Read More

Lilly ICOS's Cialis Demonstrates Efficacy In ED At 24, 36 Hours

May 29, 2002
By Kim Coghill
Lilly ICOS LLC's proposed drug for erectile dysfunction apparently gives men the ability to achieve an erection some 24 to 36 hours after taking it. Comparatively, Pfizer Inc.'s blockbuster drug Viagra offers only an eight-hour window. (BioWorld Today)
Read More

House, Senate Pass Bioterrorism Bill On To Bush For Signature

May 28, 2002
By Kim Coghill
Previous 1 2 … 118 119 120 121 122 123 124 125 126 … 142 143 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for Jan 26, 2025.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for Jan. 23, 2026.
  • Illustration of magnifying glass inspecting brain

    Neurotrimin unveiled as marker in intellectual disability

    BioWorld Science
    Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
  • DNA mutations or genetic disorder concept art

    Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease

    BioWorld Science

    Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...

  • Illustration of human body surrounded by DNA, cell and drug icons

    Cell/gene therapy sector now sustainable; China competition mounting

    BioWorld
    There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • NME Digest
    • Patents
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing